Depo-Provera / Meningioma — Signal 87

March 2024 BMJ study established a 5.6× increased meningioma risk for long-term Depo-Provera users. Pfizer faces failure-to-warn allegations. Massive plaintiff pool — Depo-Provera has been prescribed to tens of millions of women since 1992.